Clinical trial
Iressa Case Control Study in Japan
NCT00252759 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00252759 |
|---|---|
| Title | Iressa Case Control Study in Japan |
| Official title | A Nested Case-control Study to Determine the Relative Risk of and Risk Factors for Interstitial Lung Disease in a Cohort of NSCLC Patients Treated With and Without Gefitinib |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Non-small Cell Lung Cancer |
| Enrollment | 6,000 |
| Start date | Nov 1, 2003 |
| Completion | Feb 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Jan 28, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: